Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Early Acute Kidney Injury and Its Association With Survival in Patients With Metastatic Non‐Small‐Cell Lung Cancer Treated With Front‐Line Immunotherapy‐Based Therapies

Cancer Medicine(2025)10.1002/cam4.71058Source: DataRank Database

Early Acute Kidney Injury and Its Association With Survival in Patients With Metastatic Non‐Small‐Cell Lung Cancer Treated With Front‐Line Immunotherapy‐Based Therapies is a research paper published in Cancer Medicine (2025). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (9 grants)Impact (FWCI 0.00)OA: goldTopics (62)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (31)

Po‐Lan Su ORCID,Songzhu Zhao,Grace Cheng ORCID,Nicholas Jones ORCID,Kenneth Chian

Live enrichment

PubMed:40719750 PMC:PMC12302575 OpenAlex:https://openalex.org/W4412699038

National Center for Advancing Translational Sciences

Grant: UL1TR002733

National Institutes of Health

Grant: P30CA016058

National Institutes of Health

Grant: R01CA273924

NCI NIH HHS

Grant: U24 CA247648

National Institutes of Health

Grant: 3P30CA016058-15S1

CORE--HORMONE RECEPTOR LABORATORY

National Institutes of Health

Grant: 5R01CA273924-03

Cachexia-mediated FcRn Modulation and Its Impact on Anti-PD1 Therapy in Lung Cancer

National Institutes of Health

Grant: 5UL1TR002733-02

The OSU Center for Clinical and Translational Science: Advancing Today's Discoveries to Improve Health

REDCap project

FWCI

0.00

Citation Percentile

0.2%

goldLicense: cc-by

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cam4.71058

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cam4.71058

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.71058

publisherhttps://onlinelibrary.wiley.com/doi/full-xml/10.1002/cam4.71058

journalhttps://doi.org/10.1002/cam4.71058

Fields of Study

Cancer Immunotherapy and BiomarkersRenal cell carcinoma treatmentInflammatory Biomarkers in Disease Prognosis03 medical and health sciences0302 clinical medicineHumansMaleCarcinoma, Non-Small-Cell LungFemaleAcute Kidney InjuryLung NeoplasmsRetrospective StudiesMiddle AgedAgedImmune Checkpoint InhibitorsImmunotherapyAged, 80 and overAntineoplastic Combined Chemotherapy Protocols

MeSH Terms

Immune Checkpoint InhibitorsAgedAged, 80 and overAntineoplastic Combined Chemotherapy ProtocolsCarcinoma, Non-Small-Cell LungFemaleHumansImmunotherapyLung NeoplasmsMaleMiddle AgedRetrospective StudiesAcute Kidney Injury

Keywords

MedicinePembrolizumabPemetrexedInternal medicineAcute kidney injuryCarboplatinLung cancerOncologyHazard ratioCreatinineDialysisProportional hazards modelCancerChemotherapyImmunotherapyConfidence intervalSurvivalacute renal failureNon‐small‐cell Lung CancerImmune Checkpoint InhibitorsMaleAged, 80 and overLung NeoplasmsMiddle AgedCarcinoma, Non-Small-Cell LungAntineoplastic Combined Chemotherapy ProtocolsHumansFemaleResearch ArticleRetrospective StudiesAged

Sustainable Development Goals

SDG 0: Good health and well-being